5-HT3 antagonist 4
{[allProObj[0].p_purity_real_show]}
货号：A1159100
5-HT3 antagonist 4是一种 5-HT3 受体拮抗剂，可调节血清素能系统并预防小鼠糖尿病引起的抑郁表型。
5-HT3 antagonist 4 化学结构
CAS号：930478-88-9
5-HT3 antagonist 4 3D分子结构
CAS号：930478-88-9
| 规格 |
价格 |
会员价
|
库存 |
数量 |
|
{[ item.pr_size ]}
|
{[ getRatePrice(item.pr_rmb, 1,1) ]}
{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}
{[ suihuo_tips(item.pr_tag_price) ]}
|
{[ getRatePrice(item.pr_rmb, 1,1) ]}
{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]}
{[ suihuo_tips(item.pr_tag_price) ]}
|
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}
{[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]}
{[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}
|
现货 |
咨询
|
-
+
|
5-HT3 antagonist 4 纯度/质量文件 产品仅供科研
货号：A1159100
标准纯度：
{[allProObj[0].p_purity_real_show]}
-
全球学术期刊中引用的产品
- • JMC, 2024. Ambeed.
[
A919389 ,
A918471 ,
A995972
]
- • Anal. Chem., 2024, 96(50): 19947-19954. Ambeed.
[
A261947 ,
A1165388
]
- • ACS Biomater. Sci. Eng., 2024. Ambeed.
[
A220462
]
- • ACS Biomater. Sci. Eng., 2024. Ambeed.
[
A165235 ,
A110205
]
- • Pharmaceutics, 2024, 16(12): 1546. Ambeed.
[
A272538 ,
A187261 ,
A691302 ,
A506702
]
- 更多 >
5-HT3 antagonist 4 质控信息
| Hydroxyzine 2HCl |
|
|
|
|
|
|
99+% |
| Cyclizine |
✔
|
|
|
|
|
|
97% |
| Loratadine |
+
|
|
|
|
|
|
98% |
| Desloratadine |
++
Histamine H1 receptor, IC50: 51 nM
|
|
|
|
|
|
98% |
| Doxylamine succinate |
✔
|
|
|
|
|
|
99% |
| Ebastine |
✔
|
|
|
|
|
|
98% |
| Tripelennamine HCl |
+
|
|
|
|
|
|
98% |
| Meclizine dihydrochloride |
✔
|
|
|
|
|
|
98% |
| Chlorpheniramine maleate |
+++
Histamine H1 receptor, IC50: 12 nM
|
|
|
|
|
|
99% |
| Diphenhydramine HCl |
✔
|
|
|
|
|
|
99% |
| Alcaftadine |
++++
|
++
|
|
|
|
|
99%+ |
| Fexofenadine HCl |
++
Histamine H1 receptor, IC50: 246 nM
|
|
|
|
|
|
99%+ |
| Bilastine |
+++
H1 receptor, Ki: 44.15 nM
|
|
|
|
|
|
98% |
| Pemirolast potassium |
✔
|
|
|
|
|
|
98% |
| Bepotastine besilate |
+
Histamine H1 receptor, pIC50: 5.7
|
|
|
|
|
|
98% |
| Mizolastine |
+++
Histamine H1 receptor, IC50: 47 nM
|
|
|
|
|
|
98% |
| Brompheniramine maleate |
✔
|
|
|
|
|
|
98% |
| Carbinoxamine maleate salt |
✔
|
|
|
|
|
|
99+% |
| Clemastine fumarate |
++++
Histamine H1 receptor, IC50: 3 nM
|
|
|
|
|
|
98% |
| Ketotifen fumarate salt |
✔
|
|
|
|
|
|
95% |
| Rupatadine Fumarate |
++
Histamine H1 receptor, Ki: 102 nM
|
|
|
|
|
PAFR
|
98% |
| Famotidine |
|
✔
|
|
|
|
|
97% |
| Roxatidine Acetate HCl |
|
+
Histamine H2 receptor, IC50: 3.2 μM
|
|
|
|
|
98% |
| Lafutidine |
|
✔
|
|
|
|
|
99% |
| Cimetidine |
|
✔
|
|
|
|
|
98% |
| Nizatidine |
|
++++
Histamine H2 receptor, IC50: 0.9 nM
|
|
|
|
AChE
|
98% |
| Ranitidine |
|
✔
|
|
|
|
|
98% |
| Betahistine |
|
|
+
Histamine H3 receptor, IC50: 1.9 μM
|
|
|
|
99% |
| Ciproxifan maleate |
|
|
+++
Histamine H3 receptor, IC50: 9.2 nM
|
|
|
|
99%+ |
| S 38093 |
|
|
++
rat H3 receptor, Ki: 1.44 μM
human H3 receptor, Ki: 1.2 μM
|
|
|
|
98% |
| JNJ-7777120 |
|
|
|
++++
Histamine H4 receptor, Ki: 4.5 nM
|
|
|
99% |
| Azelastine HCl |
|
|
|
|
✔
|
|
98% |
| Epinastine HCl |
|
|
|
|
✔
|
|
99% |
| Levodropropizine |
|
|
|
|
✔
|
|
97% |
| Cyproheptadine hydrochloride |
|
|
|
|
✔
|
|
98% |
| Hesperetin |
|
|
|
|
✔
|
|
97% |
| Olopatadine HCl |
|
|
|
|
✔
|
|
98% |
| Mianserin hydrochloride |
|
|
|
|
✔
|
|
99+% |
| Buclizine 2HCl |
|
|
|
|
✔
|
|
97% |
| Latrepirdine 2HCl |
|
|
|
|
✔
|
GluR
|
99% |
| Cetirizine 2HCl |
|
|
|
|
✔
|
|
98% |
|
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。
|
| Desvenlafaxine |
++
|
|
|
|
|
|
|
|
98% |
| Lamotrigine |
+
5-HT (rat brain synaptosomes), IC50: 474 μM
5-HT (human platelets), IC50: 240 μM
|
|
|
|
|
|
|
|
98% |
| Venlafaxine |
✔
|
|
|
|
|
|
|
|
99% |
| Fluvoxamine maleate |
✔
|
|
|
|
|
|
|
|
99% |
| Iloperidone |
✔
|
|
|
|
|
|
|
|
99% |
| Ziprasidone HCl |
✔
|
|
|
|
|
|
|
|
98+% |
| Atomoxetine HCI |
+
|
|
|
|
|
|
|
|
98% |
| Dapoxetine HCl |
✔
|
|
|
|
|
|
|
|
97% |
| Trazodone |
✔
|
|
|
|
|
|
|
|
98+% |
| Clomipramine HCl |
✔
|
|
|
|
|
|
|
|
98% |
| Mirtazapine |
✔
|
|
|
|
|
|
|
|
99+% |
| Escitalopram oxalate |
+++
|
|
|
|
|
|
|
|
97% |
| Duloxetine |
✔
|
|
|
|
|
|
|
|
98+% |
| Sertraline HCl |
++
|
|
|
|
|
|
|
|
98% |
| Citalopram HBr |
+++
serotonin reuptake, IC50: 1.8 nM
|
|
|
|
|
|
|
|
98% |
| Latrepirdine 2HCl |
✔
|
|
|
|
|
|
|
GluR
|
99% |
| Fluoxetine HCl |
✔
|
|
|
|
|
|
|
|
99.5% |
| Paroxetine hydrochloride |
✔
|
|
|
|
|
|
|
AChR
|
99% |
| BMY 7378 |
|
++
5-HT1A, pIC50: 6.4
5-HT1D, pIC50: 5.9
|
+
|
|
|
|
|
|
97% |
| Flibanserin |
|
+++
|
+
|
|
|
|
|
|
98% |
| LY310762 |
|
+
|
|
|
|
|
|
|
99%+ |
| Cyclobenzaprine HCI |
|
|
✔
|
|
|
|
|
|
99% |
| Blonanserin |
|
|
+++
|
|
|
|
|
|
99% |
| Cyproheptadine HCl |
|
|
++++
|
|
|
|
|
|
99+% |
| Olanzapine |
|
|
✔
|
|
|
|
|
|
99+% |
| Pimavanserin hemitartrate |
|
|
+++
|
|
|
|
|
|
99% |
| Ketanserin |
|
|
+++
5-HT2C (Human), Ki: 2.5 nM
5-HT2C (Rat), Ki: 50 nM
|
|
|
|
|
|
99%+ |
| Loxapine succinate |
|
|
++
5-HT2 (human), Ki: 6.8 nM
5-HT2 (bovine), Ki: 6.6 nM
|
|
|
|
|
|
99% |
| Agomelatine |
|
|
✔
|
|
|
|
|
|
98% |
| Clozapine |
|
|
✔
|
|
|
|
|
|
98% |
| Amitriptyline |
|
|
+
|
|
|
|
|
SERT
|
99% |
| PRX-08066 maleate |
|
|
+++
|
|
|
|
|
|
98+% |
| RS-127445 |
|
|
++++
5-HT2B, pKi: 9.5
5-HT2B, pIC50: 10.4
|
|
|
|
|
|
99%+ |
| Sarpogrelate HCl |
|
|
++++
5-HT2C, Kd: 1.1 nM
5-HT2A, Kd: 2.1 nM
|
|
|
|
|
|
98% |
| Tropisetron |
|
|
|
✔
|
|
|
|
|
99% |
| Palonosetron |
|
|
|
✔
|
|
|
|
|
98% |
| Ramosetron HCl |
|
|
|
++++
5-HT3 receptor, Ki: 0.091 nM
|
|
|
|
|
98% |
| Ondansetron |
|
|
|
✔
|
|
|
|
|
99% |
| Granisetron |
|
|
|
✔
|
|
|
|
|
98% |
| Alosetron HCl |
|
|
|
✔
|
|
|
|
|
98% |
| Ondansetron hydrochloride dihydrate |
|
|
|
✔
|
|
|
|
|
98% |
| VUF10166 |
|
|
|
++++
5-HT3A, Ki: 0.04 nM
5-HT3AB, Ki: 22 nM
|
|
|
|
|
99%+ |
| Azasetron hydrochloride |
|
|
|
++++
|
|
|
|
|
99% |
| Asenapine maleate |
|
+++
5-HT1A, pKi: 8.6
5-HT1B, pKi: 8.4
|
++++
5-HT2A, pKi: 9.75
5-HT2C, pKi: 10.46
|
|
+++
|
++++
|
++++
|
|
97% |
| Risperidone |
|
++
5-HT1D, Ki: 84.6 nM
5-HT1B, Ki: 14.9 nM
|
++++
5-HT2C, Ki: 12 nM
5-HT2A, Ki: 61.9 nM
|
|
+
|
|
++
|
|
98% |
| SB 271046 HCl |
|
|
|
|
|
+++
|
|
|
99%+ |
| Intepirdine |
|
|
|
|
|
++++
|
|
|
99%+ |
| SB-269970 HCl |
|
|
|
|
|
|
++
|
|
98+% |
| BRL 15572 |
|
++
5-HT1B, pKi: 6.1
5-HT1D, pKi: 6
|
++
5-HT2B, pKi: 6.2
5-HT2A, pKi: 6.6
|
|
|
+
|
+
|
|
98% |
|
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。
|
5-HT3 antagonist 4 实验方案
| 计算器 |
|
| 存储液制备 |
 |
1mg |
5mg |
10mg |
|
1 mM
5 mM
10 mM
|
3.36mL
0.67mL
0.34mL
|
16.79mL
3.36mL
1.68mL
|
33.59mL
6.72mL
3.36mL
|
5-HT3 antagonist 4 技术信息
搜索
